BWL
CODX

Bogart Wealth LLC’s Co-Diagnostics CODX Stock Holding History

Bogart Wealth LLC’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed -$252 – 1125
2022
Q4 		$252 Hold
3
– – ﹤0.01% 951
2022
Q3 		$0 Buy
+3
New +$420 ﹤0.01% 1014
2022
Q2 		– Sell
-3
Closed -$1K – 900
2022
Q1 		$1K Hold
3
– – ﹤0.01% 726
2021
Q4 		$1K Hold
3
– – ﹤0.01% 694
2021
Q3 		$1K Hold
3
– – ﹤0.01% 673
2021
Q2 		$1K Hold
3
– – ﹤0.01% 636
2021
Q1 		$1K Hold
3
– – ﹤0.01% 585
2020
Q4 		$0 Buy
+3
New +$1.11K ﹤0.01% 463

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bogart Wealth LLC's CODX Position: Q1 2023 in Review

Bogart Wealth LLC sold out of Co-Diagnostics (CODX) in Q1 2023, closing a stake of 3 shares — an estimated $252 sold.

Bogart Wealth LLC first reported a position in CODX in Q4 2020 and held it in 8 quarters. The position peaked at $1K in Q1 2022. 51 funds tracked by Wall St. Rank hold CODX as of Q1 2023.

  • Bogart Wealth LLC reported no remaining Co-Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Bogart Wealth LLC sold 3 Co-Diagnostics shares in Q1 2023, an estimated $252.
  • Bogart Wealth LLC first reported a position in Co-Diagnostics in Q4 2020 and held it in 8 quarters.
  • Bogart Wealth LLC's Co-Diagnostics position peaked at $1K in Q1 2022.
  • 51 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2023.

Based on Bogart Wealth LLC's 13F filing for Q1 2023, filed 21 Apr 2023.